Advances in antiretroviral therapies mean people with the HIV virus now live long enough to face the problems of ageing and require holistic healthcare
Working with countries in Africa, the EU has fostered innovation that is making an important contribution to the fight against AIDS. To build on this, the new Africa-EU partnership now taking shape needs more ambitious goals
GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.
The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.
These updates are republished press releases and communications from members of the Science|Business Network
Tweets by scibus